Tuberculosis vaccine shows promise as once-fatal disease evades treatment
The nasal spray, DNA-based vaccine targets two genes to help the immune system fight drug-tolerant “persisters” that survive prolonged antibiotic therapy and contribute to relapse.
Original Source
Read the full article at Seattletimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.